HOW IS YOUR BIOLOGICS TESTING PROGRAM?
Peptides, proteins and glycoproteins require customized analyses performed to cGMP standards. Receive the benefit of SGS expertise that encompasses post-translational modification analyses as well as higher order structure, all designed to help clients comply with ICH Q6B guidelines.

Share this email: LinkedIn    Twitter    Facebook    Google+    ShareThis
HIGHER ORDER STRUCTURAL CHARACTERIZATION   STABILITY TESTING FOR BIOLOGICS
 
 
JF-04142015-Higher
 
 
JF-04072015-TestTube
Download this white paper on using multiple techniques in biophysical characterization Ensure your product’s long shelf life, learn about SGS’s custom formulation services
Download Now Find Your Solution
WEBINAR: BREAKING NEWS ON BIOSIMILARS DEVELOPMENT
JF-04072015-Webinar This 60 minute webinar will provide a look at the multi-stage development for a biosimilar, including an update of the regulatory landscape, structural characterization techniques for biosimilarity assessment, and early phase clinical research challenges. April 22, 11am EST; 5pm CET
REGISTER NOW
 
 
BIOSIMILAR SERVICES: FROM ORIGINATOR THROUGH COMPATIBILITY TO MARKET
JF-04072015-Egg SGS’s broad service portfolio delivers an integrated Biosimilar Development solution. Clients can move seamlessly through the critical stages of their biosimilar development from product characterization and biosafety testing, to full comparability studies and clinical trials.
Learn More
 
 
FOLLOW US ON LINKEDIN
JF-04072015-Lab Follow SGS’s Life Science LinkedIn Showcase page. Be one of the first to learn of new developments in the Bio/analytical laboratory and Clinical Research drug development arena.
 
Terms of Access  |   Privacy Policy
SGS SA. 1 Place des Alpes P.O. Box 2152 Geneva, 1211, Switzerland www.sgs.com
Opt out